Go to the profile of TIM MULLER, CBO CROSSJECT and Founder SCIENTEX

TIM MULLER, CBO CROSSJECT and Founder SCIENTEX

Pharmaceuticals, private equity, transition management, Crossject = needle free self injectable drugs